LBO — PAULDING MEDICAL CENTER
IRR: 17.9% | MOIC: 2.28x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
17.9%
IRR
2.28x
MOIC
$266.9M
Entry EV
$423.2M
Exit EV
$137.3M
Equity Invested
Sources & Uses
S&UTotal · $266.9M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $103.7M | 38.8% | |
| Sub Debt | $25.9M | 9.7% | |
| Equity | $137.3M | 51.5% | |
| Enterprise Value | $259.1M | 97.1% | |
| Transaction Fees | $7.8M | 2.9% | |
| Total Uses | $266.9M | 100.0% |
Interpretation
INTAt 2.28x MOIC and 17.9% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $40.3M |
| Exit Ev | $423.2M |
| Net Debt At Exit | $110.0M |
| Equity At Exit | $313.2M |
| Equity Invested | $137.3M |
| Total Value Created | $175.8M |
| Value From Growth | $151.1M |
| Value From Multiple | $13.0M |
| Value From Deleveraging | $19.5M |